Barclays PLC Neuro Pace Inc Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Barclays PLC holds 20,633 shares of NPCE stock, worth $229,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,633
Previous 20,633
-0.0%
Holding current value
$229,851
Previous $144,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NPCE
# of Institutions
52Shares Held
21.3MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.62MShares$62.6 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$37.9 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$27.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$27.1 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$13.9 Million3.46% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $277M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...